secwatch.observer — SEC 8-K summary
======================================

Issuer:     EyePoint, Inc. (EYPT)
CIK:        0001314102
Form:       8-K
Filed at:   2024-05-28T23:59:59+00:00
Accession:  0000950170-24-064879
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

EyePoint posts updated investor presentation; no specific financial updates in excerpt
--------------------------------------------------------------------------------

- Filed investor presentation dated May 2024 as Exhibit 99.1 on May 28, 2024.
- Presentation posted on company website at www.eyepointpharma.com.
- No new financial guidance, clinical data, or material events disclosed in filing summary.
- Ticker EYPT; common stock listed on Nasdaq.
- No changes to previously disclosed business outlook or pipeline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314102/000095017024064879/0000950170-24-064879-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314102/000095017024064879/eypt-20240528.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-064879

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer